Takeda Pharmaceutical Company Limited
MATRIX COMPOSITION
Last updated:
Abstract:
The present invention provides means for producing an organoid close to an organ in a living body and capable of secretion of a plasma protein and immune response. A matrix composition of the present invention provided as such means includes: (1) a first matrix containing one or more cells selected from the group consisting of vascular cells, nerve cells, and blood cells; and (2) a second matrix containing to cells constituting an organ and/or an organoid, in which the first matrix envelops the second matrix, and the first matrix has at least one opening.
Status:
Application
Type:
Utility
Filling date:
27 Mar 2020
Issue date:
23 Jun 2022